Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Crysvita
Descriptions
Burosumab-twza injection is used to treat X-linked hypophosphatemia (low phosphate levels in the blood). This medicine is also used to treat FGF23-related hypophosphatemia in patients with tumor-induced osteomalacia (soft bones) whose tumors are limited to a certain part of the body and cannot be removed by surgery.
This medicine should be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2021
Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.